Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir B Amin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMC Bioinformatics|March 11, 2011
The dChip survival analysis module for microarray dataSamir B Amin, Parantu K Shah, Aimin Yan, et al.
Blood|September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cellsZe Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Nucleic Acids Research|May 31, 2012
Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancersZhenyu Yan, Parantu K Shah, Samir B Amin, et al.
Leukemia|June 12, 2019
The effects of MicroRNA deregulation on pre-RNA processing network in multiple myelomaSophia Adamia, Ivane Abiatari, Samir B Amin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanomaYonathan Lissanu Deribe, Yanxia Shi, Kunal Rai, et al.
The Journal of Clinical Investigation|November 2, 2016
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancerBeatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
The Journal of Clinical Investigation|November 10, 2015
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancerBeatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
Cancer Cell|April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung CancerHunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.
Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.
Cell Reports|October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|March 11, 2011
The dChip survival analysis module for microarray dataSamir B Amin, Parantu K Shah, Aimin Yan, et al.
Blood|September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cellsZe Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Nucleic Acids Research|May 31, 2012
Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancersZhenyu Yan, Parantu K Shah, Samir B Amin, et al.
Leukemia|June 12, 2019
The effects of MicroRNA deregulation on pre-RNA processing network in multiple myelomaSophia Adamia, Ivane Abiatari, Samir B Amin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanomaYonathan Lissanu Deribe, Yanxia Shi, Kunal Rai, et al.
The Journal of Clinical Investigation|November 2, 2016
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancerBeatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
The Journal of Clinical Investigation|November 10, 2015
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancerBeatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
Cancer Cell|April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung CancerHunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.
Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.
Cell Reports|October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Pageof 1